Karuna Therapeutics, Inc.

CIK 1771917 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Karuna Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Mar 28, 202415-12G0001140361-24-016120
Mar 18, 202440001140361-24-013924
Mar 18, 202440001140361-24-013922
Mar 18, 202440001140361-24-013935
Mar 18, 202440001140361-24-013925
Mar 18, 2024S-8 POS0001140361-24-013745
Mar 18, 2024S-8 POS0001140361-24-013743
Mar 18, 202440001140361-24-013932
Mar 18, 2024S-8 POS0001140361-24-013744
Mar 18, 2024S-8 POS0001140361-24-013746
Mar 18, 2024S-8 POS0001140361-24-013747
Mar 18, 202440001140361-24-013931
Mar 18, 202425-NSE0001354457-24-000152
Mar 18, 202440001140361-24-013923
Mar 18, 2024POSASR0001140361-24-013731
Mar 18, 202440001140361-24-013928
Mar 18, 202440001140361-24-013934
Mar 18, 202440001140361-24-013927
Mar 18, 20248-K0001140361-24-013728
Mar 18, 202440001140361-24-013933
Mar 18, 202440001140361-24-013930
Mar 18, 202440001140361-24-013926
Mar 14, 20248-K0001140361-24-013155
Mar 14, 202410-K/A0000950170-24-031505
Mar 12, 20248-K0001140361-24-012807